Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Lobe Sciences Ltd C.LOBE

Alternate Symbol(s):  LOBED

Lobe Sciences Ltd is a technology and services company that provides real estate, financial, management, IP, and branding support for the development of transformational medicine. It is working to develop effective psilocybin-based therapeutics for the treatment of mild traumatic brain injuries and post-traumatic stress disorder and devices for the efficient application of medications.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (CSE:LOBE)

Fundamentals Snapshot (CSE:LOBE)

Opinion & Analysis (CSE:LOBE)

No current opinion is available.

Bullboard Posts (CSE:LOBE)

🎫🤑🎬 FEELING BULLISH --- Phillip J Young

<< View Post To Watch Video >>
AllForTheMoney - 13 days ago

RE:RE:RE:RE:NEWS: Roadmap for Remainder of 2022 & Early 2023 𓋼𓋺𓋼

BIG BIDS COMING IN (myself included) -- Marcin Ashley VanDyke wrote Well said !! GajjarDr wrote What is most intersting is L-130 drug. As...
Marcin - 13 days ago

RE:RE:RE:NEWS: Roadmap for Remainder of 2022 & Early 2023 𓋼𓋺𓋼

Well said !! GajjarDr wrote What is most intersting is L-130 drug. As stated in NR... "Lobe will investigate the safety and...
ashleyvandyke - June 16, 2022

RE:RE:NEWS: Roadmap for Remainder of 2022 & Early 2023 𓋼𓋺𓋼

What is most intersting is L-130 drug. As stated in NR... "Lobe will investigate the safety and tolerability of an oral drug...
GajjarDr - June 16, 2022

RE:NEWS: Roadmap for Remainder of 2022 & Early 2023 𓋼𓋺𓋼

initforthemush wrote
realmccoy - June 16, 2022

RE:NEWS: Roadmap for Remainder of 2022 & Early 2023 𓋼𓋺𓋼

initforthemush wrote
realmccoy - June 16, 2022